[VRDN] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -14.49%
YoY- -61.56%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 695 2,514 372 476 944 2,182 4,784 -72.33%
PBT -11,230 -8,896 -11,629 -10,317 -9,011 -8,714 -4,661 79.62%
Tax 133 204 339 289 362 361 167 -14.06%
NP -11,230 -8,896 -11,629 -10,317 -9,011 -8,714 -4,661 79.62%
Tax Rate - - - - - - - -
Total Cost 11,925 11,410 12,001 10,793 9,955 10,896 9,445 16.79%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -1,615.83 -353.86 -3,126.08 -2,167.44 -954.56 -399.36 -97.43 549.22%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -5.42 -4.31 -5.65 -5.02 -4.40 -4.31 -2.64 61.46%
EPS Diluted -5.42 -4.31 -5.65 -5.02 -4.40 -4.31 -2.64 61.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.